People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Pharmaceuticals, Other Technology, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alimera Sciences Inc | — | Pharmaceuticals | Series C | $173.8M | $1.1B | 2009 |
| Oraya Therapeutics Inc | — | Other Technology | Series B | $74.9M | $765.4M | 2009 |
| Spinal Kinetics Inc | — | Other Health Care | Series B | $53.7M | $28.4M | 2009 |
| Abs Topco, Llc | — | Other Health Care | Series B | $25.5M | $34.2M | 2019 |
| Pittsburgh Holdings, Inc. | — | Other | Series B | $19.8M | $329.6M | 2011 |
Mark Brooks at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Brooks on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Halak | 2 | 10 |
| Richard Ferrari | 1 | 15 |
| James Taylor | 1 | 12 |
| Michael Kaplan | 1 | 11 |
| Peter Cohn | 1 | 10 |
| Reza Zadno | 1 | 7 |
| David Milne | 1 | 7 |
| David Fitzgerald | 1 | 7 |
| Guido Neels | 1 | 7 |
| Melissa Daniels | 1 | 6 |
| Brian K. Halak | 1 | 5 |
| David Trujillo | 1 | 5 |
| Al Wiegman | 1 | 5 |
| John Onopchenko | 1 | 4 |
| Anders Hove | 1 | 4 |
| Mary T. Szela | 1 | 4 |
| Asiff Hirji | 1 | 4 |
| Peter J. Pizzo III | 1 | 3 |
| Peter Van Der Velden | 1 | 3 |
| Dan Galles | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.